Smart For Life Announces Initiation of Equity Analyst Coverage by Dawson James Securities

Rhea-AI Summary

Smart for Life, Inc. (Nasdaq: SMFL) has received a 'Buy' recommendation and an $8 price target from Dawson James Securities, indicating strong growth potential. The company specializes in marketing and manufacturing nutritional foods and supplements globally, and is pursuing a Buy-and-Build strategy with plans for acquisitions. Smart for Life aims to aggregate companies generating at least $300 million in revenues over the next three years. The full report is available through Dawson James Securities.

Positive

• Initiated 'Buy' recommendation from Dawson James Securities.
• Target price set at $8, indicating potential upside.
• Executing a Buy-and-Build strategy for growth.
• Aims to achieve $300 million in revenues from acquisitions within three years.

Negative

• None.

Initiates with “Buy” recommendation and $8 price target

MIAMI, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, today announced that Jason H. Kolbert, Managing Director & Senior Analyst at Dawson James Securities, has initiated research coverage on the Company with a “Buy” recommendation and $8 price target. The report is available for download on the Dawson James Securities website.

Any opinions, estimates or forecasts by Dawson James Securities regarding the Company’s performance are theirs alone and do not represent opinions, forecasts or predictions of Smart for Life or its management. Smart for Life does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

About Smart for Life, Inc.

Smart for Life, Inc. (Nasdaq: SMFL) is a high growth global leader in the Health & Wellness sector, marketing and manufacturing nutritional foods and supplements worldwide. Structured as a publicly held international holding company, the Company is executing a Buy-and-Build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues within the next thirty-six months. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition/Sports Illustrated Nutrition and Ceautamed Worldwide/Greens First. For more information about Smart for Life, please visit: www.smartforlifecorp.com.

Video regarding the Company’s manufacturing facility at Bonne Santé Natural Manufacturing is available at: www.bonnesantemanufacturing.com/video.

Investor material and a Fact Sheet with additional information about Smart for Life is available at: www.smartforlifecorp.com/investor-center.

Forward-Looking Statements

This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Investor Relations Contact

Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com

FAQ

What is the price target for Smart for Life (SMFL) announced by Dawson James Securities?

Dawson James Securities has set a price target of $8 for Smart for Life (SMFL).

What recommendation did Dawson James Securities give for Smart for Life (SMFL)?

Dawson James Securities initiated a 'Buy' recommendation for Smart for Life (SMFL).

What is the primary business focus of Smart for Life (SMFL)?

Smart for Life (SMFL) focuses on marketing and manufacturing nutritional foods and supplements globally.

What growth strategy is Smart for Life (SMFL) pursuing?

Smart for Life (SMFL) is pursuing a Buy-and-Build strategy aimed at acquiring companies.

What revenue target has Smart for Life (SMFL) set for its acquisitions?

Smart for Life (SMFL) aims to aggregate companies generating at least $300 million in revenues within the next three years.